Call for Paper - Upcoming Issues

Therapeutic Role of Dilatation And Curettage, Oral Contraceptive Pills and Ormeloxifene (Sevista) in Abnormal Uterine Bleeding

International Journal of Medical Science
© 2017 by SSRG - IJMS Journal
Volume 4 Issue 9
Year of Publication : 2017
Authors : Dr. Lalit D Kapadia and Dr. Payal H.Parmar
10.14445/23939117/IJMS-V4I9P101
pdf
How to Cite?

Dr. Lalit D Kapadia and Dr. Payal H.Parmar, "Therapeutic Role of Dilatation And Curettage, Oral Contraceptive Pills and Ormeloxifene (Sevista) in Abnormal Uterine Bleeding," SSRG International Journal of Medical Science, vol. 4,  no. 9, pp. 1-5, 2017. Crossref, https://doi.org/10.14445/23939117/IJMS-V4I9P101

Abstract:

Total 140 cases of menorrhagia were selected on basis of history, clinical examination and investigation who came in OPD of department of Obstetrics and Gynaecologist B.J.Medical Colleage, Ahmedabad, between august 2016 to June 2017. Dilation and curettage shows improved result and increased compliance is because of prompt and immediate result,less hospital stay decresed morbidity, probably no side effects. Oral contraceptive pills is the choice of treatment in patients of younger age group with dysfunctional uterine bleeding, and patient who were not feet for surgery but most of the patients show noncomplaince towards the treatment due to longer duration of treatment, and also because of misunderstanding as contraceptive . Ormeloxifene is treatment of choice in patient who are not feet for surgery and contraindicated for Oral contraceptive use. Though the treatment is effective but most of patient shows non-compliance towards the treatment due to longer duration and timing.

Keywords:

Though the treatment is effective but most of patient shows non-compliance towards the treatment due to longer duration and timing.

References:

[1] Marjoribanks, Jane; Lethaby, Anne; Farquhar, Cindy (2016-01-29). "Surgery versus medical therapy for heavy menstrual bleeding". The Cochrane Database of Systematic Reviews (1): CD003855. ISSN 1469-493X. PMID 26820670. doi:10.1002/14651858.CD003855.pub3.
[2] Kjerulff KH, Erickson BA, Langenberg PW (1996 Feb;86(2):195-9.). "Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992". Am J Public Health. 86: 195–9. PMC 1380327 Freely accessible. PMID 8633735. doi:10.2105/ajph.86.2.195. Check date values in: |date= (help)
[3] "CG44 Heavy menstrual bleeding: Understanding NICE guidance" (PDF). National Institute for Health and Clinical Excellence (UK). 24 January 2007.
[4] Weeks AD (2000). "Menorrhagia and hypothyroidism. Evidence supports association between hypothyroidism and menorrhagia". BMJ. 320: 649. PMC 1117669 Freely accessible. PMID 10698899. doi:10.1136/bmj.320.7235.649.
[5] Kaunitz, Andrew M.; Meredith, Susanna; Inki, Pirjo; Kubba, Ali; Sanchez-Ramos, Luis (2009-05-01). "Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis". Obstetrics and Gynecology. 113 (5): 1104–1116. ISSN 0029-7844. PMID 19384127.doi:10.1097/AOG.0b013e3181a1d3ce.